Published in Melanoma Res on February 01, 2016
Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin (2014) 11.09
Overdiagnosis and overtreatment in cancer: an opportunity for improvement. JAMA (2013) 5.56
Cancers with increasing incidence trends in the United States: 1999 through 2008. CA Cancer J Clin (2012) 4.13
Recent trends in cutaneous melanoma incidence and death rates in the United States, 1992-2006. J Am Acad Dermatol (2011) 3.11
Correlation between prognostic factors and increasing age in melanoma. Ann Surg Oncol (2004) 2.18
Influence of death certificate errors on cancer mortality trends. J Natl Cancer Inst (1993) 1.83
Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol (2008) 1.60
Conditional survival among cancer patients in the United States. Oncologist (2010) 1.51
Prognosis for long-term survivors of cancer. Ann Oncol (2007) 1.47
Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers. J Clin Oncol (2010) 1.34
Health care system and socioeconomic factors associated with variance in use of sentinel lymph node biopsy for melanoma in the United States. J Clin Oncol (2009) 1.33
Conditional survival estimates improve over 5 years for melanoma survivors with node-positive disease. Ann Surg Oncol (2010) 1.24
Conditional survival estimates improve over time for patients with advanced melanoma: results from a population-based analysis. Cancer (2010) 1.19
Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry. J Clin Oncol (2013) 1.19
Sentinel Lymph Node Biopsy Use Among Melanoma Patients 75 Years of Age and Older. Ann Surg Oncol (2015) 1.15
Conditional survival of cancer patients: an Australian perspective. BMC Cancer (2012) 1.14
Older Age is Associated with a Higher Incidence of Melanoma Death but a Lower Incidence of Sentinel Lymph Node Metastasis in the SEER Databases (2003-2011). Ann Surg Oncol (2015) 1.14
Epidemiology and treatment of melanoma in elderly patients. Nat Rev Clin Oncol (2010) 1.08
Cutaneous melanoma in the elderly: epidemiology, prognosis and treatment. Melanoma Res (2010) 0.90
Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma. N Engl J Med (2015) 14.71
Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci Transl Med (2011) 5.82
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol (2013) 5.56
Hospital volume and late survival after cancer surgery. Ann Surg (2007) 2.93
Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol (2013) 2.43
Critical evaluation of the scientific content in clinical practice guidelines. Cancer (2014) 2.04
Hospital factors and racial disparities in mortality after surgery for breast and colon cancer. J Clin Oncol (2009) 2.02
American Society of Clinical Oncology provisional clinical opinion: chronic hepatitis B virus infection screening in patients receiving cytotoxic chemotherapy for treatment of malignant diseases. J Clin Oncol (2010) 1.91
The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid (2011) 1.85
Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer (2007) 1.83
Critical evaluation of oncology clinical practice guidelines. J Clin Oncol (2013) 1.78
The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma. Cancer (2007) 1.64
Frequency of nonsentinel lymph node metastasis in melanoma. Ann Surg Oncol (2002) 1.62
Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol (2003) 1.52
Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery (2007) 1.47
Variation in Transfusion Practices and the Effect on Outcomes After Noncardiac Surgery. Ann Surg (2015) 1.46
Surgeon training and use of radioactive iodine in stage I thyroid cancer patients. Ann Surg Oncol (2012) 1.43
Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells. Ann Surg (2008) 1.39
Dermatofibrosarcoma protuberans: how wide should we resect? Ann Surg Oncol (2010) 1.35
Clinical practice guideline: improving voice outcomes after thyroid surgery. Otolaryngol Head Neck Surg (2013) 1.32
Interval sentinel lymph nodes in melanoma. Arch Surg (2002) 1.32
Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol (2011) 1.16
Lymph node evaluation in colon cancer: assessing the link between quality indicators and quality. JAMA (2011) 1.16
Ipilimumab and radiation therapy for melanoma brain metastases. Cancer Med (2013) 1.15
Lymphatic mapping and sentinel lymph node biopsy in patients with melanoma: a meta-analysis. J Clin Oncol (2011) 1.12
Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals. Pediatr Infect Dis J (2012) 1.06
Prognostic significance of a positive nonsentinel lymph node in cutaneous melanoma. Ann Surg Oncol (2009) 1.04
Randomized phase II trial of sorafenib with temsirolimus or tipifarnib in untreated metastatic melanoma (S0438). Clin Cancer Res (2012) 1.04
Validation of subareolar and periareolar injection techniques for breast sentinel lymph node biopsy. Arch Surg (2004) 1.02
Patterns of early recurrence after sentinel lymph node biopsy for melanoma. Am J Surg (2002) 1.02
Classifying cause of death after cancer surgery. Surg Innov (2006) 0.99
Sentinel lymph node biopsy for head and neck melanomas. Ann Surg Oncol (2003) 0.96
Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer (2009) 0.94
Validation of statistical predictive models meant to select melanoma patients for sentinel lymph node biopsy. Ann Surg Oncol (2011) 0.94
Phase II trial of sorafenib in combination with carboplatin and paclitaxel in patients with metastatic uveal melanoma: SWOG S0512. PLoS One (2012) 0.92
E2F-1 gene therapy induces apoptosis and increases chemosensitivity in human pancreatic carcinoma cells. Tumour Biol (2002) 0.92
Sentinel lymph node biopsy in patients with ductal carcinoma in situ: a proposal. Cancer (2002) 0.91
The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer. J Clin Endocrinol Metab (2013) 0.91
Evidence-based clinical practice guidelines on the use of sentinel lymph node biopsy in melanoma. Am Soc Clin Oncol Educ Book (2013) 0.90
Significance of multiple lymphatic basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy. Ann Surg Oncol (2006) 0.90
Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Cancer (2011) 0.88
Approach to and treatment of thyroid disorders in the elderly. Med Clin North Am (2012) 0.86
Hospital lymph node counts and survival after radical cystectomy. Cancer (2008) 0.86
Trends in imaging after diagnosis of thyroid cancer. Cancer (2015) 0.86
Factors that influence radioactive iodine use for thyroid cancer. Thyroid (2013) 0.86
Differences in perioperative care at low- and high-mortality hospitals with cancer surgery. Ann Surg Oncol (2014) 0.86
Evidence-based surgical practice in academic medical centers: consistently anecdotal? J Gastrointest Surg (2010) 0.85
Tree-based model for thyroid cancer prognostication. J Clin Endocrinol Metab (2014) 0.84
Quality measurement in cancer care delivery. Ann Surg Oncol (2011) 0.84
Racial disparities in esophageal cancer outcomes. Ann Surg Oncol (2012) 0.83
Molecular diagnostics of melanoma fine-needle aspirates: a cytology-histology correlation study. Am J Clin Pathol (2012) 0.83
Surgical options for advanced/metastatic gastrointestinal stromal tumors. Curr Probl Cancer (2011) 0.83
Clinicopathologic features of primary Merkel cell carcinoma: a detailed descriptive analysis of a large contemporary cohort. Dermatol Surg (2013) 0.83
Palpable breast carcinomas: a hypothesis for clinically relevant lymphatic drainage in sentinel lymph node biopsy. Breast J (2003) 0.82
Surgical options for localized and advanced gastrointestinal stromal tumors. J Surg Oncol (2011) 0.82
Conditional survival in patients with thyroid cancer. Thyroid (2014) 0.82
Implementation of a small bowel obstruction guideline improves hospital efficiency. Surgery (2012) 0.82
Surgical management of gastrointestinal stromal tumors. Curr Probl Cancer (2011) 0.82
Intensity of follow-up after melanoma surgery. Ann Surg Oncol (2013) 0.81
Radiation versus resection for Merkel cell carcinoma. Cancer (2010) 0.80
Comment on the article "Highest isotope count does not predict sentinel node positivity in all breast cancer patients," by Martin et al., August 2001, Annals of Surgical Oncology. Ann Surg Oncol (2002) 0.80
Concurrent whole brain radiotherapy and bortezomib for brain metastasis. Radiat Oncol (2013) 0.80
Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part II: Management of stage IV disease. J Am Acad Dermatol (2013) 0.80
Merkel cell carcinoma, version 1.2014. J Natl Compr Canc Netw (2014) 0.79
C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells. Cancer Gene Ther (2002) 0.79
Pancreatic Resection Results in a Statewide Surgical Collaborative. Ann Surg Oncol (2015) 0.79
Tumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells. Transl Oncogenomics (2007) 0.79
New insights in risk stratification of differentiated thyroid cancer. Curr Opin Oncol (2014) 0.79
Host glycosaminoglycan confers susceptibility to bacterial infection in Drosophila melanogaster. Infect Immun (2008) 0.79
Do micromorphometric features of metastatic deposits within sentinel nodes predict nonsentinel lymph node involvement in melanoma? Ann Surg Oncol (2008) 0.79
Surgical Referral for Colorectal Liver Metastases: A Population-Based Survey. Ann Surg Oncol (2015) 0.78
NCCN Guidelines implementation in the multidisciplinary Merkel Cell Carcinoma Program at the University of Michigan. J Natl Compr Canc Netw (2014) 0.78
V559A and N822I double KIT mutant melanoma with predictable response to imatinib? Pigment Cell Melanoma Res (2011) 0.77
Basal Cell Skin Cancer, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 0.76
Sentinel lymph node biopsy for breast cancer: improvement in results over time. Breast J (2004) 0.76
Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part I: Management of stage III disease. J Am Acad Dermatol (2013) 0.76
Review of evidence-based support for pretreatment imaging in melanoma. J Natl Compr Canc Netw (2009) 0.76
Sentinel lymph node biopsy in melanoma: controversies and current guidelines. Future Oncol (2014) 0.75
Sentinel lymph node biopsy in melanoma: final results of MSLT-I. Future Oncol (2014) 0.75
Surveillance chest X-rays for melanoma: prescription or proscription? Ann Surg Oncol (2008) 0.75
Case 19-2008: Merkel-cell carcinoma. N Engl J Med (2008) 0.75
Re: Diabetes mellitus and risk of colorectal cancer in the Singapore Chinese Health Study. J Natl Cancer Inst (2006) 0.75
Feasibility of serial biopsies of large dysplastic nevi as a melanoma chemoprevention model. J Am Acad Dermatol (2011) 0.75
Micrometastases in sentinel lymph nodes: not getting lost in translation. Ann Surg Oncol (2012) 0.75
Multi-institutional assessment of sphincter preservation for rectal cancer. Ann Surg Oncol (2014) 0.75
Effects of contiguous scars in dermatoscopic evaluation of clinically atypical melanocytic nevi. J Am Acad Dermatol (2012) 0.75
Utilization and Outcomes of Inpatient Surgery at Safety-Net Hospitals. J Health Care Poor Underserved (2016) 0.75
Tribute to Alfred E. Chang. J Surg Oncol (2011) 0.75
Discordance in histopathologic evaluation of melanoma sentinel lymph node biopsy with clinical follow-up: results from a prospectively collected database. Ann Surg Oncol (2014) 0.75
Global surgical oncology: addressing the global surgical oncology disease burden. Ann Surg Oncol (2015) 0.75
Hospital Ownership of a Postacute Care Facility Influences Discharge Destinations After Emergent Surgery. Ann Surg (2016) 0.75